Saltar al contenido

Prestige Consumer Healthcare Inc. (PBH) stock: revenue, earnings & dividend

Prestige Consumer Healthcare Inc. (PBH, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PBH · NYSE Pharma & Biotech US-NY

Key figures

Fiscal year
2025
Revenue
1.09 bn $
Revenue growth
-4.3 %
Revenue growth 5y (p.a.)
2.9 %
Net income
190 m $
Net margin
17.5 %
Operating margin
28.4 %
Earnings per share (diluted)
3.91 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
3.49 bn $
Equity
1.83 bn $
Equity ratio
52.4 %
Return on equity
10.4 %
Cash
62.4 m $
Operating cash flow
258 m $
Free cash flow
246 m $
Shares outstanding
47,397,106

History

Revenue by fiscal year

2016 882 m $
2017 1.04 bn $
2018 976 m $
2019 963 m $
2020 943 m $
2021 1.09 bn $
2022 1.13 bn $
2023 1.13 bn $
2024 1.14 bn $
2025 1.09 bn $

Net income by fiscal year

2016 69.4 m $
2017 340 m $
2018 -35.8 m $
2019 142 m $
2020 165 m $
2021 205 m $
2022 -82.3 m $
2023 209 m $
2024 215 m $
2025 190 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.09 bn $190 m $3.91 $–258 m $
20241.14 bn $215 m $4.29 $–252 m $
20231.13 bn $209 m $4.17 $–249 m $
20221.13 bn $-82.3 m $-1.65 $–230 m $
20211.09 bn $205 m $4.04 $–260 m $
2020943 m $165 m $3.25 $–236 m $
2019963 m $142 m $2.78 $–217 m $
2018976 m $-35.8 m $-0.69 $–189 m $
20171.04 bn $340 m $6.34 $–210 m $
2016882 m $69.4 m $1.30 $–149 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)